CFDE Data Portal | Search LINC02177

	Label	Description
	LINC02177 Gene (Entity type)	ENSG00000261617 - long intergenic non-protein coding RNA 2177
	GSE56010 adenosine 4 v 1 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE145195 PPP2R3B overexpression 4 v 5 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE182680 GSE182683 dexamethasone 0 v 12 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE202744 CDK9 inhibition Toyocamycin 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GTEx Breast 20-29 vs 50-59 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Pancreas 20-29 vs 70-79 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Heart 20-29 vs 70-79 Down Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Thyroid 20-29 vs 30-39 Up Gene Set (Entity type)	A Gene Set from GTEx
	GTEx Breast 20-29 vs 30-39 Down Gene Set (Entity type)	A Gene Set from GTEx

LINC02177

ENSG00000261617 - long intergenic non-protein coding RNA 2177

GSE56010 adenosine 4 v 1 human dn

A Gene Set from LINCS

GSE145195 PPP2R3B overexpression 4 v 5 human dn

A Gene Set from LINCS

GSE182680 GSE182683 dexamethasone 0 v 12 human up

A Gene Set from LINCS

GSE202744 CDK9 inhibition Toyocamycin 1 v 0 human dn

A Gene Set from LINCS

GTEx Breast 20-29 vs 50-59 Down

A Gene Set from GTEx

GTEx Pancreas 20-29 vs 70-79 Down

A Gene Set from GTEx

GTEx Heart 20-29 vs 70-79 Down

A Gene Set from GTEx

GTEx Thyroid 20-29 vs 30-39 Up

A Gene Set from GTEx

GTEx Breast 20-29 vs 30-39 Down

A Gene Set from GTEx

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.